Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takahiro Fukazawa

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Pharmacology|October 6, 2022
p53 status modifies cytotoxic activity of lactoferrin under hypoxic conditionsMaryami Yuliana Kosim, Takahiro Fukazawa, Mutsumi Miyauchi, et al.
NPJ Microgravity|July 25, 2018
Erratum: Publisher Correction: Simulated microgravity attenuates myogenic differentiation via epigenetic regulationsTakuma Furukawa, Keiji Tanimoto, Takahiro Fukazawa, et al.
BMC Complementary and Alternative Medicine|November 7, 2014
Inhibitory activities of selected Kampo formulations on human aldose reductaseToshihisa Onoda, Chikako Ishikawa, Takahiro Fukazawa, et al.
Cells|October 14, 2022
In Vitro Transfection of Up-Regulated Genes Identified in Favorable-Outcome Neuroblastoma into Cell LinesYoko Hiyama, Emi Yamaoka, Takahiro Fukazawa, et al.
Cancers|June 13, 2025
ADAM32 Oncogene in Hepatoblastoma Is Regulated by IGF2BP2Takahiro Fukazawa, Keiji Tanimoto, Masato Kojima, et al.
NPJ Microgravity|May 31, 2018
Simulated microgravity attenuates myogenic differentiation via epigenetic regulationsTakuma Furukawa, Keiji Tanimoto, Takahiro Fukazawa, et al.
Plos One|September 12, 2025
Validation of the FVB/N-Tg(HSA* LR)20bCath mice of myotonic dystrophy using swallowing function assessment, histology, and immunofluorescence analysisRie Asayama, Kaori Tanaka-Nishikubo, Jun Iwanami, et al.
Cancers|October 14, 2022
Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for TherapyTakahiro Fukazawa, Keiji Tanimoto, Emi Yamaoka, et al.
Scientific Reports|November 25, 2021
Single-cell DNA and RNA sequencing of circulating tumor cellsMasato Kojima, Takanori Harada, Takahiro Fukazawa, et al.
International Journal of Molecular Sciences|March 27, 2025
Differential Effects of the Prolyl-Hydroxylase Inhibitor on the Cellular Response to RadiationMasaki Murao, Takahiro Fukazawa, Ujjal K Bhawal, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|October 6, 2022
p53 status modifies cytotoxic activity of lactoferrin under hypoxic conditionsMaryami Yuliana Kosim, Takahiro Fukazawa, Mutsumi Miyauchi, et al.
NPJ Microgravity|July 25, 2018
Erratum: Publisher Correction: Simulated microgravity attenuates myogenic differentiation via epigenetic regulationsTakuma Furukawa, Keiji Tanimoto, Takahiro Fukazawa, et al.
BMC Complementary and Alternative Medicine|November 7, 2014
Inhibitory activities of selected Kampo formulations on human aldose reductaseToshihisa Onoda, Chikako Ishikawa, Takahiro Fukazawa, et al.
Cells|October 14, 2022
In Vitro Transfection of Up-Regulated Genes Identified in Favorable-Outcome Neuroblastoma into Cell LinesYoko Hiyama, Emi Yamaoka, Takahiro Fukazawa, et al.
Cancers|June 13, 2025
ADAM32 Oncogene in Hepatoblastoma Is Regulated by IGF2BP2Takahiro Fukazawa, Keiji Tanimoto, Masato Kojima, et al.
NPJ Microgravity|May 31, 2018
Simulated microgravity attenuates myogenic differentiation via epigenetic regulationsTakuma Furukawa, Keiji Tanimoto, Takahiro Fukazawa, et al.
Plos One|September 12, 2025
Validation of the FVB/N-Tg(HSA* LR)20bCath mice of myotonic dystrophy using swallowing function assessment, histology, and immunofluorescence analysisRie Asayama, Kaori Tanaka-Nishikubo, Jun Iwanami, et al.
Cancers|October 14, 2022
Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for TherapyTakahiro Fukazawa, Keiji Tanimoto, Emi Yamaoka, et al.
Scientific Reports|November 25, 2021
Single-cell DNA and RNA sequencing of circulating tumor cellsMasato Kojima, Takanori Harada, Takahiro Fukazawa, et al.
International Journal of Molecular Sciences|March 27, 2025
Differential Effects of the Prolyl-Hydroxylase Inhibitor on the Cellular Response to RadiationMasaki Murao, Takahiro Fukazawa, Ujjal K Bhawal, et al.
Pageof 3